ASX:MVF Monash IVF Group (MVF) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MVF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume9.00 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.46%Price TargetN/A Stock AnalysisStock Analysis Get Monash IVF Group alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Monash IVF Group Stock (ASX:MVF)Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. MVF Stock News HeadlinesApril 8, 2024 | finance.yahoo.comReturns At Monash IVF Group (ASX:MVF) Appear To Be Weighed DownMarch 6, 2024 | finance.yahoo.comMonash IVF Group (ASX:MVF) Is Paying Out A Dividend Of A$0.025April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 2, 2024 | finance.yahoo.comHere's Why We're Wary Of Buying Monash IVF Group's (ASX:MVF) For Its Upcoming DividendFebruary 17, 2024 | finance.yahoo.comMonash IVF Group Limited (ASX:MVF) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadFebruary 17, 2024 | finance.yahoo.comMonash IVF Group Limited (ASX:MVF) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?February 13, 2024 | wsj.comMonash IVF Group Ltd.February 7, 2024 | msn.comIVF add-on may be expensive, invasive, and ineffective, study findsApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. February 6, 2024 | msn.comA common add-on in IVF may be an expensive waste of time, study revealsFebruary 1, 2024 | afr.comMonash IVF Group LimitedNovember 21, 2023 | finance.yahoo.comHere's Why Monash IVF Group Limited's (ASX:MVF) CEO Compensation Is The Least Of Shareholders' ConcernsOctober 23, 2023 | finance.yahoo.comInvestors Could Be Concerned With Monash IVF Group's (ASX:MVF) Returns On CapitalOctober 12, 2023 | finance.yahoo.comCryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVFOctober 8, 2023 | finance.yahoo.comAn Intrinsic Calculation For Monash IVF Group Limited (ASX:MVF) Suggests It's 48% UndervaluedOctober 4, 2023 | msn.comASX Escrow Watch: Which lithium and resources companies are releasing shares?September 24, 2023 | finance.yahoo.comDo Monash IVF Group's (ASX:MVF) Earnings Warrant Your Attention?August 26, 2023 | finance.yahoo.comMonash IVF Group (ASX:MVF) Has Affirmed Its Dividend Of A$0.022August 22, 2023 | finance.yahoo.comMonash IVF Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsAugust 14, 2023 | finance.yahoo.comMonash IVF Group's (ASX:MVF) investors will be pleased with their strong 134% return over the last three yearsJuly 7, 2023 | finance.yahoo.comMonash IVF Group Limited (ASX:MVF) most popular amongst retail investors who own 59% of the shares, institutions hold 29%June 8, 2023 | msn.comWILSONS Maintains Monash IVF Group (ASX:MVF) Overweight RecommendationMay 27, 2023 | fool.com.auMonash IVF Group Ltd & Virtus Health Ltd: 2 great growth stocks?May 15, 2023 | finance.yahoo.comCapital Allocation Trends At Monash IVF Group (ASX:MVF) Aren't IdealApril 30, 2023 | finance.yahoo.comMonash IVF Group Limited (ASX:MVF) Shares Could Be 36% Below Their Intrinsic Value EstimateMarch 24, 2023 | finance.yahoo.comDoes Monash IVF Group Limited's (ASX:MVF) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?March 7, 2023 | finance.yahoo.comMonash IVF Group (ASX:MVF) shareholders have earned a 15% CAGR over the last three yearsSee More Headlines Receive MVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Monash IVF Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/27/2018Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:MVF CUSIPN/A CIKN/A Webwww.monashivfgroup.com.au Phone+61-3-94208235FaxN/AEmployees867Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.06 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth8.25Net Income$23.97 million Net Margins10.16% Pretax MarginN/A Return on Equity8.68% Return on Assets5.74% Debt Debt-to-Equity Ratio43.35 Current Ratio0.36 Quick Ratio0.43 Sales & Book Value Annual Sales$235.97 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow27.14 Book ValueA$0.71 per share Price / BookN/AMiscellaneous Outstanding Shares389,640,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.46 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Michael D. KnaapCEO, MD & Executive DirectorMr. Malik JainudeenGroup CFO & Company SecretaryDr. Hamish HamiltonChief Operating OfficerDr. Richard Charles Henshaw M.D.Executive DirectorDr. Deirdre Zander-Fox BSc. (Hons.)Dip. of Mgt, Ph.D., Chief Scientific OfficerMr. Thierry PanthierChief Information OfficerMs. Fiona AllenChief Marketing OfficerMs. Peggy NorthChief People & Culture OfficerMs. Tedd FuellChief Governance & Risk OfficerMr. Johannes LagerwijManaging Director of AsiaMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersMichael KnaapSold 517,433 sharesTotal: $657,139.91 ($1.27/share) MVF Stock Analysis - Frequently Asked Questions How were Monash IVF Group's earnings last quarter? Monash IVF Group Limited (ASX:MVF) posted its quarterly earnings results on Monday, August, 27th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. Monash IVF Group had a net margin of 10.16% and a trailing twelve-month return on equity of 8.68%. Is Monash IVF Group a good dividend stock? Monash IVF Group (ASX:MVF) pays an annual dividend of A$0.05 per share and currently has a dividend yield of 3.46%. The dividend payout ratio is 83.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for MVF. What other stocks do shareholders of Monash IVF Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS) and This page (ASX:MVF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monash IVF Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
